Zepbound Obesity Treatment - Search News

News

Zepbound beats Wegovy for weight loss

The Mercury News · 2d

Zepbound trims more belly fat than Wegovy, study shows

The obesity drug helped people trim about two inches more off their waists than Wegovy in the first head-to-head study of the rival medicines.

Medical Xpress · 2d

Zepbound outperforms Wegovy in head-to-head weight loss study

A new study has found that people taking Eli Lilly's obesity drug Zepbound lost almost 50% more weight than those using Novo Nordisk's Wegovy.

Eli Lilly's Zepbound Shows Superior Weight Loss Over Novo Nordisk's Wegovy In Head-To-Head Trial

Eli Lilly and Company's Zepbound demonstrated superior weight reduction compared to Novo Nordisk's Wegovy in a 72-week head-to-head trial.

Novo Nordisk's latest bet on obesity pills

The Wall Street Journal on MSN · 1h

Novo Nordisk and Septerna Strike $2.2 Billion Deal to Develop Obesity Pills

The deal with U.S. biotech Septerna will see the companies develop pills to treat obesity, type 2 diabetes and other cardiometabolic diseases.

InvestorsHub on MSN · 20h

Novo Nordisk Inks $2.2 Billion Deal with Septerna to Advance Obesity and Diabetes Treatments

Novo Nordisk (NYSE: NVO) has entered into a collaboration and licensing agreement with U.S.-based biotech firm Septerna (NASDAQ: SEPN) to co-develop oral small molecule therapies targeting obesity, type 2 diabetes,

Novo Nordisk's latest bet on obesity pills: $2.2 billion for biotech Sapterna

Novo Nordisk (NVO) announced a new $2.2 billion deal with San Francisco-based biotech Sapterna (SEPN) for obesity pills.

MedPage Today on MSN2d

Zepbound and Wegovy Go Head to Head for Obesity: And the Winner Is ...

Tirzepatide (Zepbound) came out on top against semaglutide (Wegovy) for treating obesity in the head-to-head SURMOUNT-5 trial ...

3d

Why Patients Are Being Forced to Switch to a 2nd-Choice Obesity Drug

CVS Caremark decided to stop offering Zepbound in favor of Wegovy for weight loss. It’s the latest example of limits imposed ...

More data back Zepbound over Wegovy for weight loss

"These data confirm Zepbound as a leading treatment option for people living with obesity and equip healthcare ...

Pharmalittle: We’re reading about Trump drug-pricing plan, obesity drug trial data, and more

President Trump said he would sign an executive order to base U.S. drug prices on what other countries pay — usually far less ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results